[Infection control strategies for antimicrobial-resistance]

Area of Science:

• Infectious Diseases
• Hospital Epidemiology
• Antimicrobial Stewardship

Context:

• Antimicrobial resistance (AMR) poses a significant global health threat, especially impacting critically ill patients due to potential treatment failures.
• Methicillin-resistant Staphylococcus aureus (MRSA) is a persistent concern in Japanese hospitals.
• Emerging multidrug-resistant pathogens, including vancomycin-resistant Enterococci (VRE), multidrug-resistant Pseudomonas (MDRP), and extended-spectrum beta-lactamase (ESBL) producers, are increasingly reported as nosocomial pathogens.

Purpose:

• To highlight the escalating threat of AMR in healthcare settings, particularly in Japan.
• To emphasize the necessity of strategic interventions for controlling the spread of drug-resistant pathogens.
• To underscore the importance of specialized expertise in combating antimicrobial resistance.

Summary:

• Effective control of AMR requires tailored antimicrobial therapy based on local susceptibility data and comprehensive multidisciplinary management strategies.
• The Centers for Disease Control and Prevention (CDC) outlines 12 essential steps for preventing AMR in hospitalized patients, focusing on infection prevention, accurate diagnosis and treatment, judicious antimicrobial use, and transmission control.
• A critical shortage of infectious diseases experts in Japan presents a challenge to implementing these vital AMR control recommendations.

Impact:

• Implementing evidence-based AMR control strategies can reduce treatment failures and improve outcomes for critically ill patients.
• Strengthening antimicrobial stewardship programs and infection control measures is essential for mitigating the impact of nosocomial infections.
• Addressing the shortage of infectious diseases specialists is paramount for enhancing Japan's capacity to combat the growing threat of antimicrobial resistance.